Genetic basis of rheumatoid arthritis

Biomedicine and Pharmacotherapy

Volumn 60, Issue 10, 2006, Pages 656-662

  Orozco, G ^a   Rueda, B ^a   Martin, J ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Genetic factors; Rheumatoid arthritis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENZYME; LEUKOCYTE ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; PEPTIDYLARGININE DEIMINASE 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; HYDROLASE; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE MIGRATION ENHANCEMENT FACTOR; PEPTIDYLARGININE DEIMINASE TYPE IV; PROTEIN TYROSINE PHOSPHATASE; TYROSINE PROTEIN PHOSPHATASE, NON RECEPTOR TYPE 22; TYROSINE PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 22;

ARTICLE; AUTOIMMUNE DISEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC TRAIT; HEREDITY; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; GENETIC HETEROGENEITY; GENETICS; PATHOLOGY; REVIEW;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ARTHRITIS, RHEUMATOID; CHEMOTACTIC FACTORS, MACROPHAGE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; HYDROLASES; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33751412076     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.09.003     Document Type: Article

References (112)

1. Wordsworth P., and Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann. Rheum. Dis. 50 (1991) 343-346
2. del Junco D., Luthra H.S., Annegers J.F., Worthington J.W., and Kurland L.T. The familial aggregation of rheumatoid arthritis and its relationship to the HLA-DR4 association. Am. J. Epidemiol. 119 (1984) 813-829
3. Silman A.J., MacGregor A.J., Thomson W., Holligan S., Carthy D., Farhan A., et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol. 32 (1993) 903-907
4. Ollier W., and Thomson W. Population genetics of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 18 (1992) 741-759
5. Gregersen P.K., Silver J., and Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30 (1987) 1205-1213
6. Ollier W., and Hajeer A. Does the HLA-DRB1 shared epitope really contribute that much to the development or severity of rheumatoid arthritis?. In: Isenberg D.A., and Tucker L.B. (Eds). Controversies in Rheumatology (1997), Martin Dunitz, London 1-12
7. Brintnell W., Zeggini E., Barton A., Thomson W., Eyre S., Hinks A., et al. Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p. Arthritis Rheum. 50 (2004) 3823-3830
8. Jawaheer D., Li W., Graham R.R., Chen W., Damle A., Xiao X., et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am. J. Hum. Genet. 71 (2002) 585-594
9. Pascual M., Mataran L., Jones G., Shing D., van der Slik A.R., Giphart M.J., et al. HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes. Scand. J. Rheumatol. 31 (2002) 275-278
10. Deighton C.M., Walker D.J., Griffiths I.D., and Roberts D.F. The contribution of HLA to rheumatoid arthritis. Clin. Genet. 36 (1989) 178-182
11. Dawn Teare M., and Barrett J.H. Genetic linkage studies. Lancet 366 (2005) 1036-1044
12. Cornelis F., Faure S., Martinez M., Prud'homme J.F., Fritz P., Dib C., et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. USA 95 (1998) 10746-10750
13. Shiozawa S., Hayashi S., Tsukamoto Y., Goko H., Kawasaki H., Wada T., et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int. Immunol. 10 (1998) 1891-1895
14. Jawaheer D., Seldin M.F., Amos C.I., Chen W.V., Shigeta R., Monteiro J., et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68 (2001) 927-936
15. MacKay K., Eyre S., Myerscough A., Milicic A., Barton A., Laval S., et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46 (2002) 632-639
16. Eyre S., Barton A., Shephard N., Hinks A., Brintnell W., MacKay K., et al. Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis Rheum. 50 (2004) 729-735
17. Jawaheer D., Seldin M.F., Amos C.I., Chen W.V., Shigeta R., Etzel C., et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48 (2003) 906-916
18. Osorio Y.F.J., Bukulmez H., Petit-Teixeira E., Michou L., Pierlot C., Cailleau-Moindrault S., et al. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum. 50 (2004) 2757-2765
19. John S., Shephard N., Liu G., Zeggini E., Cao M., Chen W., et al. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am. J. Hum. Genet. 75 (2004) 54-64
20. Tamiya G., Shinya M., Imanishi T., Ikuta T., Makino S., Okamoto K., et al. Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum. Mol. Genet. 14 (2005) 2305-2321
21. Gaffney P.M., Kearns G.M., Shark K.B., Ortmann W.A., Selby S.A., Malmgren M.L., et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sub-pair families. Proc. Natl. Acad. Sci. USA 95 (1998) 14875-14879
22. Shai R., Quismorio Jr. F.P., Li L., Kwon O.J., Morrison J., Wallace D.J., et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum. Mol. Genet. 8 (1999) 639-644
23. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371 (1994) 130-136
24. Merriman T., Twells R., Merriman M., Eaves I., Cox R., Cucca F., et al. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum. Mol. Genet. 6 (1997) 1003-1010
25. Fisher S.A., Lanchbury J.S., and Lewis C.M. Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16. Arthritis Rheum. 48 (2003) 1200-1206
26. Choi S.J., Rho Y.H., Ji J.D., Song G.G., and Lee Y.H. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45 (2006) 166-170
27. Lander E.S., and Schork N.J. Genetic dissection of complex traits. Science 265 (1994) 2037-2048
28. Cordell H.J., and Clayton D.G. Genetic association studies. Lancet 366 (2005) 1121-1131
29. Mayeux R. Mapping the new frontier: complex genetic disorders. J. Clin. Invest. 115 (2005) 1404-1407
30. Hattersley A.T., and McCarthy M.I. What makes a good genetic association study?. Lancet 366 (2005) 1315-1323
31. Dunbar S.A. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chim. Acta 363 (2006) 71-82
32. John S., and Worthington J. Genetic epidemiology. Approaches to the genetic analysis of rheumatoid arthritis. Arthritis Res. 3 (2001) 216-220
33. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat. Genet. 29 (2001) 306-309
34. Huizinga T.W., Pisetsky D.S., and Kimberly R.P. Associations, populations, and the truth: recommendations for genetic association studies in Arthritis & Rheumatism. Arthritis Rheum. 50 (2004) 2066-2071
35. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36 (2004) 337-338
36. Gregersen P.K. Gaining insight into PTPN22 and autoimmunity. Nat. Genet. 37 (2005) 1300-1302
37. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75 (2004) 330-337
38. Orozco G., Sanchez E., Gonzalez-Gay M.A., Lopez-Nevot M.A., Torres B., Caliz R., et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 219-224
39. Lee A.T., Li W., Liew A., Bombardier C., Weisman M., Massarotti E.M., et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 6 (2005) 129-133
40. Criswell L.A., Pfeiffer K.A., Lum R.F., Gonzales B., Novitzke J., Kern M., et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76 (2005) 561-571
41. Viken M.K., Amundsen S.S., Kvien T.K., Boberg K.M., Gilboe I.M., Lilleby V., et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun. 6 (2005) 271-273
42. Zhernakova A., Eerligh P., Wijmenga C., Barrera P., Roep B.O., and Koeleman B.P. Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun. 6 (2005) 459-461
43. Hinks A., Barton A., John S., Bruce I., Hawkins C., Griffiths C.E., et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum. 52 (2005) 1694-1699
44. van Oene M., Wintle R.F., Liu X., Yazdanpanah M., Gu X., Newman B., et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum. 52 (2005) 1993-1998
45. Seldin M.F., Shigeta R., Laiho K., Li H., Saila H., Savolainen A., et al. Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun. 6 (2005) 720-722
46. Simkins H.M., Merriman M.E., Highton J., Chapman P.T., O'Donnell J.L., Jones P.B., et al. Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum. 52 (2005) 2222-2225
47. Steer S., Lad B., Grumley J.A., Kingsley G.H., and Fisher S.A. Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum. 52 (2005) 358-360
48. Wesoly J., van der Helm-van Mil A.H., Toes R.E., Chokkalingam A.P., Carlton V.E., Begovich A.B., et al. Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. Arthritis Rheum. 52 (2005) 2948-2950
49. Carlton V.E., Hu X., Chokkalingam A.P., Schrodi S.J., Brandon R., Alexander H.C., et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am. J. Hum. Genet. 77 (2005) 567-581
50. Dieude P., Garnier S., Michou L., Petit-Teixeira E., Glikmans E., Pierlot C., et al. Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res. Ther. 7 (2005) R1200-R1207
51. Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson E.W., et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am. J. Hum. Genet. 77 (2005) 1044-1060
52. Harrison P., Pointon J.J., Farrar C., Brown M.A., and Wordsworth B.P. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 45 (2006) 1009-1011
53. Gregersen P.K., and Batliwalla F. PTPN22 and rheumatoid arthritis: gratifying replication. Arthritis Rheum. 52 (2005) 1952-1955
54. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75 (2004) 504-507
55. Wu H., Cantor R.M., Graham D.S., Lingren C.M., Farwell L., Jager P.L., et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum. 52 (2005) 2396-2402
56. Reddy M.V., Johansson M., Sturfelt G., Jonsen A., Gunnarsson I., Svenungsson E., et al. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun. 6 (2005) 658-662
57. Smyth D., Cooper J.D., Collins J.E., Heward J.M., Franklyn J.A., Howson J.M., et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 (2004) 3020-3023
58. Velaga M.R., Wilson V., Jennings C.E., Owen C.J., Herington S., Donaldson P.T., et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J. Clin. Endocrinol. Metab. 89 (2004) 5862-5865
59. Skorka A., Bednarczuk T., Bar-Andziak E., Nauman J., and Ploski R. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin. Endocrinol. (Oxf.) 62 (2005) 679-682
60. Canton I., Akhtar S., Gavalas N.G., Gawkrodger D.J., Blomhoff A., Watson P.F., et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun. 6 (2005) 584-587
61. Martin M.C., Oliver J., Urcelay E., Orozco G., Gomez-Garcia M., Lopez-Nevot M.A., et al. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease. Tissue Antigens 66 (2005) 314-317
62. Rueda B., Nunez C., Orozco G., Lopez-Nevot M.A., de la Concha E.G., Martin J., et al. C1858T functional variant of PTPN22 gene is not associated with celiac disease genetic predisposition. Hum. Immunol. 66 (2005) 848-852
63. Begovich A.B., Caillier S.J., Alexander H.C., Penko J.M., Hauser S.L., Barcellos L.F., et al. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am. J. Hum. Genet. 76 (2005) 184-187
64. Matesanz F., Rueda B., Orozco G., Fernandez O., Leyva L., Alcina A., et al. Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J. Neurol. 252 (2005) 994-995
65. Bottini N., Vang T., Cucca F., and Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18 (2006) 207-213
66. Vang T., Congia M., Macis M.D., Musumeci L., Orru V., Zavattari P., et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37 (2005) 1317-1319
67. Johansson M., Arlestig L., Hallmans G., and Rantapaa-Dahlqvist S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res. Ther. 8 (2005) R19
68. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2 (2002) 116-126
69. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
70. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5 (1996) 1075-1080
71. Donner H., Braun J., Seidl C., Rau H., Finke R., Ventz M., et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82 (1997) 4130-4132
72. Heward J.M., Allahabadia A., Armitage M., Hattersley A., Dodson P.M., Macleod K., et al. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J. Clin. Endocrinol. Metab. 84 (1999) 2398-2401
73. Seidl C., Donner H., Fischer B., Usadel K.H., Seifried E., Kaltwasser J.P., et al. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 51 (1998) 62-66
74. Yanagawa T., Gomi K., Nakao E.I., and Inada S. CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis. J. Rheumatol. 27 (2000) 2740-2742
75. Vaidya B., Pearce S.H., Charlton S., Marshall N., Rowan A.D., Griffiths I.D., et al. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology (Oxford) 41 (2002) 180-183
76. Lee C.S., Lee Y.J., Liu H.F., Su C.H., Chang S.C., Wang B.R., et al. Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese. Clin. Rheumatol. 22 (2003) 221-224
77. Lei C., Dongqing Z., Yeqing S., Oaks M.K., Lishan C., Jianzhong J., et al. Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur. J. Hum. Genet. 13 (2005) 823-828
78. Suppiah V., O'Doherty C., Heggarty S., Patterson C.C., Rooney M., and Vandenbroeck K. The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland. Exp. Mol. Pathol. 80 (2006) 141-146
79. Matsushita M., Tsuchiya N., Shiota M., Komata T., Matsuta K., Zama K., et al. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 54 (1999) 578-584
80. Takeuchi F., Kawasugi K., Mori M., Nakaue N., Kobayashi N., Kuwata S., et al. The genetic contribution of CTLA-4 dimorphisms in promoter and exon 1 regions in Japanese patients with rheumatoid arthritis. Scand. J. Rheumatol. 35 (2006) 154-155
81. Gonzalez-Escribano M.F., Rodriguez R., Valenzuela A., Garcia A., Garcia-Lozano J.R., and Nunez-Roldan A. CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 53 (1999) 296-300
82. Barton A., Myerscough A., John S., Gonzalez-Gay M., Ollier W., and Worthington J. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis. Rheumatology (Oxford) 39 (2000) 63-66
83. Milicic A., Brown M.A., and Wordsworth B.P. Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians. Tissue Antigens 58 (2001) 50-54
84. Barton A., Jury F., Eyre S., Bowes J., Hinks A., Ward D., et al. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum. 50 (2004) 748-752
85. Hadj Kacem H., Kaddour N., Adyel F.Z., Bahloul Z., and Ayadi H. HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology (Oxford) 40 (2001) 1370-1374
86. Lee Y.H., Choi S.J., Ji J.D., and Song G.G. No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter (-318) genes with rheumatoid arthritis in the Korean population. Scand. J. Rheumatol. 31 (2002) 266-270
87. Liu M.F., Wang C.R., Chen P.C., and Lin T.L. CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritis. Clin. Rheumatol. 23 (2004) 180-181
88. Rodriguez M.R., Nunez-Roldan A., Aguilar F., Valenzuela A., Garcia A., and Gonzalez-Escribano M.F. Association of the CTLA4 3′ untranslated region polymorphism with the susceptibility to rheumatoid arthritis. Hum. Immunol. 63 (2002) 76-81
89. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349 (2003) 1907-1915
90. Orozco G., Torres B., Nunez-Roldan A., Gonzalez-Escribano M.F., and Martin J. Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis. Tissue Antigens 64 (2004) 667-670
91. Zhernakova A., Eerligh P., Barrera P., Wesoly J.Z., Huizinga T.W., Roep B.O., et al. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum. Genet. 118 (2005) 58-66
92. Han S., Li Y., Mao Y., and Xie Y. Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis. Hum. Genet. 118 1 (2005) 123-132
93. Panayi G.S. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?. Rheumatology (Oxford) 44 Suppl 2 (2005) ii3-ii7
94. Nielen M.M., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50 (2004) 380-386
95. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., Hallmans G., Wadell G., Stenlund H., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48 (2003) 2741-2749
96. van Gaalen F.A., Linn-Rasker S.P., van Venrooij W.J., de Jong B.A., Breedveld F.C., Verweij C.L., et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 50 (2004) 709-715
97. Kroot E.J., de Jong B.A., van Leeuwen M.A., Swinkels H., van den Hoogen F.H., van't Hof M., et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43 (2000) 1831-1835
98. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34 (2003) 395-402
99. Ikari K., Kuwahara M., Nakamura T., Momohara S., Hara M., Yamanaka H., et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum. 52 (2005) 3054-3057
100. Kang C.P., Lee H.S., Ju H., Cho H., Kang C., and Bae S.C. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 54 (2006) 90-96
101. Barton A., Bowes J., Eyre S., Spreckley K., Hinks A., John S., et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50 (2004) 1117-1121
102. Harney S.M., Meisel C., Sims A.M., Woon P.Y., Wordsworth B.P., and Brown M.A. Genetic and genomic studies of PADI4 in rheumatoid arthritis. Rheumatology (Oxford) 44 (2005) 869-872
103. Caponi L., Petit-Teixeira E., Sebbag M., Bongiorni F., Moscato S., Pratesi F., et al. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann. Rheum. Dis. 64 (2005) 587-593
104. Martinez A., Valdivia A., Pascual-Salcedo D., Lamas J.R., Fernandez-Arquero M., Balsa A., et al. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford) 44 (2005) 1263-1266
105. Hoppe B., Haupl T., Gruber R., Kiesewetter H., Burmester G.R., Salama A., et al. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res. Ther. 8 (2006) R34
106. Calandra T., and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3 (2003) 791-800
107. Mikulowska A., Metz C.N., Bucala R., and Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J. Immunol. 158 (1997) 5514-5517
108. Donn R.P., Shelley E., Ollier W.E., and Thomson W. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 44 (2001) 1782-1785
109. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 46 (2002) 2402-2409
110. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3 (2002) 170-176
111. Barton A., Lamb R., Symmons D., Silman A., Thomson W., Worthington J., et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 4 (2003) 487-491
112. Radstake T.R., Sweep F.C., Welsing P., Franke B., Vermeulen S.H., Geurts-Moespot A., et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 52 (2005) 3020-3029